Stock Analiz

Cypherpunk Technologies Inc. CYPH

Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026

$1.87Market cap $202M
Open the interactive analysis →

Cypherpunk Technologies Inc. (CYPH) is a healthcare company listed in the US with a market value of about $202M.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is value (2/5); the weakest is future growth (0/5).

Key numbers: a P/E of 3.0, a 5-year average ROIC of -81%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 100% below the current price.

About Cypherpunk Technologies

Cypherpunk Technologies is listed in the US and classified in biotechnology: pharmaceutical preparations. It was profitable in 1 of the last 10 years in our data. Its share count rose by 524% over three years (dilution for shareholders).

Score: 0.8 / 5

Value2/5
Future growth0/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)3.0
Forward P/E3.7
P/FCF—
P/S—
P/B1.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price−100%

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-2705.8%
ROIC (5-yr avg.)-81.0%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 10 years

Fiscal year2025202420232022202120202019201820172016
Revenue————$2M$2M————
Net income$5M-$68M-$81M-$55M-$41M-$28M-$33M-$23M-$30M-$26M
Free cash flow——————-$27M—-$22M-$25M
EPS (diluted)$0.07$-1.81$-3.98$-4.82$-4.70$-6.30$-14.70$-21.10$-33.10—
Net margin————-2705.8%-1834.3%————
ROIC-21.1%-156.7%-113.8%-75.3%-38.2%-60.5%—-222.3%-289.5%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 1 analysts is $4.90, 162% above the current price; targets range from $4.90 to $4.90; the consensus rating is “none”; expected EPS is $-0.04 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is Cypherpunk Technologies’s P/E ratio?

About 3.0, based on the last twelve months of diluted earnings per share (forward P/E about 3.7).

Is Cypherpunk Technologies stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 100% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Cypherpunk Technologies pay a dividend?

Not currently.

Is Cypherpunk Technologies a good stock to buy?

We do not give buy or sell advice. Cypherpunk Technologies scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.